These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1161009)

  • 1. Letter: LSD and dopamine receptors.
    Pycock C; Anlezark G
    Nature; 1975 Sep; 257(5521):69-70. PubMed ID: 1161009
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
    Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
    Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD as an agonist of dopamine receptors in the striatum.
    Pieri L; Pieri M; Haefely W
    Nature; 1974 Dec; 252(5484):586-8. PubMed ID: 4431521
    [No Abstract]   [Full Text] [Related]  

  • 4. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
    Creese I; Burt DR; Synder SH
    Life Sci; 1975 Dec; 17(11):1715-9. PubMed ID: 1207384
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
    Whitaker PM; Seeman P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 8. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the antagonism of ergot alkaloids and dopamine by phenothiazines.
    Stone TW
    Experientia; 1974 Jul; 30(7):827-9. PubMed ID: 4847689
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of serotonin and dopamine receptors in Aplysia tissues: analysis by [3H]LSD binding and adenylate cyclase stimulation.
    Drummond AH; Bucher F; Levitan IB
    Brain Res; 1980 Feb; 184(1):163-77. PubMed ID: 7357415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo.
    Duchemin AM; Quach TT; Rose C; Schwartz JC
    Life Sci; 1979 Jan; 24(5):401-9. PubMed ID: 431327
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical aspects of dopamine agonists.
    Kehr W; Carlsson A; Lindqvist M
    Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
    [No Abstract]   [Full Text] [Related]  

  • 14. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
    De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
    Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD labels a novel dopamine receptor in molluscan nervous system.
    Drummond AH; Bucher F; Levitan IB
    Nature; 1978 Mar; 272(5651):368-70. PubMed ID: 24805
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective blocking action of LSD on inhibitory dopamine receptors.
    Sato M; Sawada M
    Neuropharmacology; 1975 Nov; 14(11):883-6. PubMed ID: 1207882
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.